Sujay Kango is CCO & VP at ACCELERON PHARMA INC (XLRN). They have made 7 open-market trades across 2 companies since 2016, most recently 2021-11-19.
CIK 0001336503
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| XLRN | SELL | 2021-09-27 | 2021-09-27 | $175.00 | $875K | -2.3% | -3.2% | N/A |
| XLRN | SELL | 2021-09-21 | 2021-09-22 | $150.03 | $750K | +12.9% | +12.5% | N/A |
| XLRN | SELL | 2021-03-02 | 2021-03-04 | $135.89 | $1.3M | +8.4% | +10.2% | -2.3% |
| XLRN | SELL | 2021-01-04 | 2021-01-06 | $125.38 | $2.5M | +7.6% | +4.0% | +12.6% |
| XLRN | SELL | 2020-02-13 | 2020-02-14 | $94.09 | $112K | -8.4% | -23.2% | +3.7% |
| XLRN | SELL · 10b5-1 | 2020-01-03 | 2020-01-03 | $51.37 | $25K | +8.0% | +85.0% | +66.2% |
| INFI | SELL | 2016-12-13 | 2016-12-14 | $1.27 | $53K | +20.3% | +22.0% | +139.8% |
| INFI | SELL | 2016-12-12 | 2016-12-14 | $1.28 | $191K | +20.3% | +22.0% | +139.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.